Categories

Muscarinic Agonists

US$ 1250

Muscarinic Agonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Agonists

09-15 2016   Pages: 60

Muscarinic Acetylcholine Receptor M5 Antagonists

US$ 1250

Muscarinic Acetylcholine Receptor M5 Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Acetylcholine Receptor M5 Antagonists.

09-15 2016   Pages: 60

Muscarinic Acetylcholine Receptor M4 Antagonists

US$ 1250

Muscarinic Acetylcholine Receptor M4 Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Acetylcholine Receptor M4 Antagonists.

09-15 2016   Pages: 60

Muscarinic Acetylcholine Receptor M3 Antagonists

US$ 1250

Muscarinic Acetylcholine Receptor M3 Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Acetylcholine Receptor M3 Antagonists.

09-15 2016   Pages: 60

Muscarinic Acetylcholine Receptor M2 Antagonists

US$ 1250

Muscarinic Acetylcholine Receptor M2 Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Acetylcholine Receptor M2 Antagonists.

09-15 2016   Pages: 60

Muscarinic Acetylcholine Receptor M1 Antagonists

US$ 1250

Muscarinic Acetylcholine Receptor M1 Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Acetylcholine Receptor M1 Antagonists.

09-15 2016   Pages: 60

Muscarinic Acetylcholine Receptor (mAChR) Antagonists

US$ 1250

Muscarinic Acetylcholine Receptor (mAChR) Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Acetylcholine Receptor (mAChR) Antagonists.

09-15 2016   Pages: 60

Murine Double Minute 2 (MDM2) Inhibitors

US$ 1250

Murine Double Minute 2 (MDM2) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Murine Double Minute 2 (MDM2) Inhibitors.

09-15 2016   Pages: 60

Mu Partial Agonists

US$ 1250

Mu Partial Agonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Mu Partial Agonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

09-15 2016   Pages: 60

Mu Antagonists

US$ 1250

Mu Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Mu Antagonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

09-15 2016   Pages: 60
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample